|
Introduction................................................................................................ 225
' y K3 k! n3 k$ SRegulatory Requirements Are Enforced by Law................................. 225
! A0 @) G, m }# w9 I9 MMake Regulatory Affairs Cost-Effective................................................ 225
/ t) G# Y0 g9 i, Z: [1 @3 K/ IRegulatory Requirements Improve Device Safety and
: f! n/ w+ o& T* @6 }6 CEffectiveness ........................................................................................ 225
; u2 B. K9 ^2 P& ERegulatory Affairs Requires Good Judgment ...................................... 226" T8 ]: L: d2 w/ J, O
FDA Overview and Authority................................................................... 226% D# {$ j( E( T* x# c- n
Important FDA Jurisdiction Acts, History, and Assistance................. 227
5 U: H' x. E' P1 jOnline Assistance .................................................................................. 227* ~1 b; Q0 ^) E& B$ K9 s. w4 S
The Basics: Short Discussion of Establishment Registration,) Q! ~1 J* ~ T. f
Device Submissions, Device Listing, and Device: j% z8 |1 n9 b2 v }4 \7 ^* R3 X
Classification............................................................................................. 2284 p, Y* r& T4 H
Establishment Registration .................................................................... 228
" `/ t+ s' w1 PDevice Listing ........................................................................................ 228
1 B) O; X; c \8 U% j u: W3 S; qDevice Classification ............................................................................. 229
% L: e0 j% Q R) NDevice Functional Classification........................................................... 230, f) O7 k2 P" [& f5 d0 M
510(k) Premarket Notification .............................................................. 230
7 e6 t% ~8 J; B# Z6 X8 XSubstantial Equivalence......................................................................... 231
7 m. v0 _; W7 ` wPremarket Approval Submission .......................................................... 232
! m4 Z* n. \3 \9 p" hInvestigational Device Exemption and Supporting Studies ............... 232+ k/ [8 e* ~( M7 ~; x
Third-Party Submission Review by Accredited Parties....................... 233
% g- }: b) h6 `: u4 N' n% xImporting into the U.S.......................................................................... 2343 F( S: W! N8 h. W" {0 z3 h# X
Initial Importers................................................................................. 2346 d6 [. I! U/ o
Exporting Devices ................................................................................. 234
( o: l9 H" K# \6 mCertificates for Foreign Government............................................... 235/ }% l3 H( ^3 e. a9 z0 C* ]4 t
Additional Regulations by Different States.......................................... 235
+ D; _1 j$ ~) C, bSpecial Considerations............................................................................... 236
0 S# D+ h, L- L+ ~* o: rExemptions from 510(k) and GMP Requirements.............................. 236! X( [% e0 H/ w
Class I Devices .................................................................................. 236: p5 A9 W' |7 t& u" q1 K3 M
Class II Devices................................................................................. 236
& y' u6 P' B+ [Special 510(k) ........................................................................................ 237% \% {2 d* n) x$ L3 L; S% G
Abbreviated 510(k)................................................................................ 238
1 p1 |5 h4 o9 EDe Novo1 Y1 Y: ^0 w; Y% R& A5 e
.................................................................................................. 238& D8 V. B* D1 X
Product Development Protocol............................................................ 239
' J! o4 s- y: ]' N% l7 qHumanitarian Use Device/Humanitarian Device Exemption............. 239
, v) ]' y+ v ZGood Quality and Procedural Practices .................................................. 240
* r% R, y: I+ z8 L3 L5 `$ z; SQuality System Regulations (QSR)....................................................... 240
: c9 z0 u, W) A3 @1 E+ d* ?Quality System Inspection Technique (QSIT)..................................... 2413 b# A; d3 S- h
Good Clinical Practice .......................................................................... 2419 P7 R) z1 Q* o% B
Good Laboratory Practices ................................................................... 2426 X i; k8 \9 C% `1 Y/ Q
Regulations ........................................................................................ 242
* `& l, J2 I# {- C0 F tPreclinical Studies.................................................................................. 242. O+ G# p/ b4 @2 `% C
Summary of Title 21 of the Code of Federal Regulations,
0 w2 p# v4 P9 u7 t( @, T& J V7 S% u- K3 JParts 800 to 1299, for Medical Devices ................................................. 243& R) [' Z! q4 O4 E+ U
Part 800: General Requirements........................................................... 243
8 F A p s8 c! A kPart 801: Labeling.................................................................................. 243 }: K6 Z3 Z& P7 A W2 C; C
Part 803: Medical Device Reporting (MDR)........................................ 244. T0 @9 _3 a8 A8 f
Part 806: Medical Devices: Reports of Corrections
8 m# E1 `5 a: \, E. G* O* P3 |) iand Removals ...................................................................................... 246
: ~ `. l/ u& }! A& |Part 807: Establishment Registration and Device Listing for6 x" ]! B( @" c5 t" G+ z9 e
Manufacturer and Individual Importers of Devices ......................... 246& m, a- N, @) J
Part 808: Exemptions from Federal Preemption of State and' {$ Z& B* u" G
Local Medical Device Requirements .................................................. 248$ n2 c0 I- V0 N0 \% s l0 a4 v5 u5 s
Part 809:
5 _. `. O$ Y1 R0 b& w0 y0 R# LIn Vitro
9 S* Q2 m; ^9 E8 rDiagnostic Products for Human Use .................... 248
1 U8 d! [4 {6 e8 f! p+ HPart 810: Medical Device Recall Authority.......................................... 249+ T0 F1 i: D- O/ B- l
Part 812: Investigational Device Exemptions...................................... 250: U/ h( {+ c9 X+ c- u
Part 820: Quality System Regulation.................................................... 257
1 [& v) }/ b/ nPart 821: Medical Device Tracking Requirements .............................. 259
6 ~4 F" y9 }$ vPart 822: Postmarket Surveillance ........................................................ 261
" S( }6 W! \: P* [# ?Part 860: Medical Device Classification Procedures ........................... 262+ Q( z2 H7 s2 ^$ n
Part 861: Procedures for Performance Standards7 j+ D7 i1 l; P9 F% K
Development ....................................................................................... 263
6 ^& w9 |( e3 m- ^8 J* ]Parts 862 to 1050................................................................................... 2641 N. E* s% a* Y9 t' ?
Abbreviations.............................................................................................. 265
) L# z: D$ L9 f4 L, f; ]7 ^, ZInternational and National Standard Abbreviations............................ 265: R& D- F" u* f
Regulatory Abbreviations ...................................................................... 265 |
本帖子中包含更多资源
您需要 登录 才可以下载或查看,没有帐号?注册安规
x
|